Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients

Authors

  • Tae Heon Kim
  • Chan Kyo Kim
  • Byung Kwan Park
  • Hwang Gyun Jeon
  • Byung Chang Jeong
  • Seong Il Seo
  • Hyun Moo Lee
  • Han Yong Choi
  • Seong Soo Jeon

DOI:

https://doi.org/10.5489/cuaj.3896

Abstract

Introduction: We assessed the correlation between the apparent diffusion coefficient (ADC) and pathological Gleason score (GS) of prostate cancer patients.

Methods: A total of 125 patients who underwent multiparametric magnetic resonance imaging before radical prostatectomy for prostate cancer were included in this study. ADC values were compared with different GS. We used receiver operating characteristic analysis and determined the ADC cutoff value to differentiate tumours with a GS of 6 from those with a GS ≥7.

Results: We identified 34 patients (27.2%) with a GS of 6; 33 patients (26.4%) with a GS of 7; 22 patients (17.6%) with a GS of 8; and 36 patients (28.8%) with a GS of ≥9. The mean ADC value for disease with a GS of 6 was 0.914 ± 0.161 x10-3 mm2/s; GS of 7: 0.741 ± 0.164 x10-3 mm2/s; GS of 8: 0.679 ± 0.130 x10-3 mm2/s; and GS of ≥9: 0.593 ± 0.089 x10-3 mm2/s. An ADC value of 0.830 ×10−3mm2/s was the best cutoff value to identify prostate cancer with a GS of 6.

Conclusions: We observed an inverse relationship between GS and ADC value. Moreover, a cutoff ADC value may help differentiate disease with a GS of 6 from disease with a GS ≥7.

Downloads

Download data is not yet available.

Downloads

Published

2016-11-10

How to Cite

Kim, T. H., Kim, C. K., Park, B. K., Jeon, H. G., Jeong, B. C., Seo, S. I., Lee, H. M., Choi, H. Y., & Jeon, S. S. (2016). Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients. Canadian Urological Association Journal, 10(11-12), E377–82. https://doi.org/10.5489/cuaj.3896

Issue

Vol. 10 No. 11-12 (2016): CUAJ November

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.